Trauma - Tranexamic Acid and Chronic Subdural Hematoma Recurrence

In this episode, we delve into the management of chronic subdural hematomas with a focus on the role of tranexamic acid. We examine findings from a single-center propensity score-matched analysis published in BMC Neurology in 2026, which investigated the revision rates and postoperative volume changes of chronic subdural hematomas treated with burr hole craniotomy either with or without tranexamic acid. The study meticulously analyzed patient data to compare outcomes between the two treatment strategies. Key findings offer valuable insights into how tranexamic acid might influence recurrence and hematoma evolution post-surgery, with direct implications for clinical decision-making in neurosurgical practice. This discussion is based on the full text of the published research. This information is intended for medical professionals and should not be considered a substitute for professional medical advice.